Childhood Asthma: Low and Middle-Income Countries Perspective.


Journal

Acta medica academica
ISSN: 1840-2879
Titre abrégé: Acta Med Acad
Pays: Bosnia and Herzegovina
ID NLM: 101587903

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 09 03 2020
accepted: 30 05 2020
entrez: 15 11 2020
pubmed: 16 11 2020
medline: 18 9 2021
Statut: ppublish

Résumé

Our aim is to review current asthma epidemiology, achievements from the last 10 years, and persistent challenges of asthma management and control in low-middle income countries (LMICs). Despite global efforts, asthma continues to be an important public health problem worldwide, particularly in poorly resourced settings. Several epidemiological studies in the last decades have shown significant variability in the prevalence of asthma globally, but generally a marked increase in LMICs resulting in significant morbidity and mortality. Poverty, air pollution, climate change, exposure to indoor allergens, urbanization and diet are some of the factors that contribute to inadequate control and poor outcomes in developing countries. Although asthma guidelines have been developed to raise awareness and improve asthma diagnosis and treatment, problems with underdiagnosis and undertreatment are still common. In addition, important social, financial, cultural and healthcare barriers are common obstacles in LMICs in achieving control. Given the high burden of asthma in these countries, adaptation and implementation of national asthma guidelines tailored to local needs should be a public health priority. Governmental commitment, education, better health system infrastructure, access to care and effective asthma medications are the cornerstone of achieving success. CONCLUSION: Asthma poses significant challenges to LMICs. Whilst there are ongoing efforts in improving asthma diagnosis and decreasing asthma burden in LMICs; reasons for inadequate asthma control are also common and difficult to tackle. Improving asthma diagnosis, access to appropriate treatment and decreasing risk factors should be key goals to reduce asthma morbidity and mortality worldwide.

Identifiants

pubmed: 33189123
pii: ama2006-124.296
doi: 10.5644/ama2006-124.296
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-190

Informations de copyright

Copyright © 2020 by Academy of Sciences and Arts of Bosnia and Herzegovina.

Auteurs

Manuel E Soto-Martínez (ME)

Respiratory Department, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Caja Costarricense Seguro Social, San José, Costa Rica; Section of Pediatrics, School of Medicine, Universidad de Costa Rica, San José, Costa Rica. mesotom@ccss.sa.cr.

Manuel E Soto-Quiros (ME)

Respiratory Medicine, Section of Pediatrics, Hospital CIMA San José, San José, Costa Rica.

Adnan Custovic (A)

National Heart and Lung Institute, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH